Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Poliovirus type 2 antigen (formaldehyde inactivated)
- Development stage
- Approved
- Lead developer
- Sanofi
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
Poliovirus type 2 antigen (formaldehyde inactivated) is a suspension of purified and formaldehyde-inactivated poliovirus Type 2, typically derived from the MEF‑1 strain. It is used as part of the inactivated polio vaccine (IPV) for active immunization against paralytic disease caused by infection with wild-type or vaccine-derived Type 2 polioviruses. The mechanism of action involves stimulating the immune system to produce neutralizing antibodies against the virus, thereby conferring protective immunity. This component is included both as a monovalent and as part of trivalent or combination vaccines for infants, children, and adults[1][4][7]. The primary indication is prevention of polio; it does not treat active infections.
- Brand names
- IpolKinrixPediarixPentacelQuadracelVaxelis
- Other names
- IPV type 2 antigen
Beyond the preview
Go deeper on Poliovirus type 2 antigen (formaldehyde inactivated).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Poliovirus type 2 antigen (formaldehyde inactivated).